Global RNA-Based Therapeutics and Vaccines Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Based on the RNA-Based Therapeutics and Vaccines market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global RNA-Based Therapeutics and Vaccines market covered in Chapter 5:
Regulus Therapeutics, Inc.
Arbutus Biopharma Corp.
BioNTech AG
Alnylam Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc.
Santaris Pharma A/S (A Roche Company)
miRagen Therapeutics
Dicerna Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc.
CureVac AG
Marina Biotech, Inc.
Moderna Therapeutics, Inc.
In Chapter 6, on the basis of types, the RNA-Based Therapeutics and Vaccines market from 2015 to 2025 is primarily split into:
RNA-based Therapeutics
RNA-Based Vaccines
In Chapter 7, on the basis of applications, the RNA-Based Therapeutics and Vaccines market from 2015 to 2025 covers:
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global RNA-Based Therapeutics and Vaccines market covered in Chapter 5:
Regulus Therapeutics, Inc.
Arbutus Biopharma Corp.
BioNTech AG
Alnylam Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc.
Santaris Pharma A/S (A Roche Company)
miRagen Therapeutics
Dicerna Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc.
CureVac AG
Marina Biotech, Inc.
Moderna Therapeutics, Inc.
In Chapter 6, on the basis of types, the RNA-Based Therapeutics and Vaccines market from 2015 to 2025 is primarily split into:
RNA-based Therapeutics
RNA-Based Vaccines
In Chapter 7, on the basis of applications, the RNA-Based Therapeutics and Vaccines market from 2015 to 2025 covers:
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 MARKET OVERVIEW
1.1 Product Definition and Market Characteristics
1.2 Global RNA-Based Therapeutics and Vaccines Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 Regulus Therapeutics, Inc.
5.1.1 Regulus Therapeutics, Inc. Company Profile
5.1.2 Regulus Therapeutics, Inc. Business Overview
5.1.3 Regulus Therapeutics, Inc. RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Regulus Therapeutics, Inc. RNA-Based Therapeutics and Vaccines Products Introduction
5.2 Arbutus Biopharma Corp.
5.2.1 Arbutus Biopharma Corp. Company Profile
5.2.2 Arbutus Biopharma Corp. Business Overview
5.2.3 Arbutus Biopharma Corp. RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Arbutus Biopharma Corp. RNA-Based Therapeutics and Vaccines Products Introduction
5.3 BioNTech AG
5.3.1 BioNTech AG Company Profile
5.3.2 BioNTech AG Business Overview
5.3.3 BioNTech AG RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 BioNTech AG RNA-Based Therapeutics and Vaccines Products Introduction
5.4 Alnylam Pharmaceuticals, Inc.
5.4.1 Alnylam Pharmaceuticals, Inc. Company Profile
5.4.2 Alnylam Pharmaceuticals, Inc. Business Overview
5.4.3 Alnylam Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Alnylam Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Products Introduction
5.5 Quark Pharmaceuticals, Inc.
5.5.1 Quark Pharmaceuticals, Inc. Company Profile
5.5.2 Quark Pharmaceuticals, Inc. Business Overview
5.5.3 Quark Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Quark Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Products Introduction
5.6 Santaris Pharma A/S (A Roche Company)
5.6.1 Santaris Pharma A/S (A Roche Company) Company Profile
5.6.2 Santaris Pharma A/S (A Roche Company) Business Overview
5.6.3 Santaris Pharma A/S (A Roche Company) RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Santaris Pharma A/S (A Roche Company) RNA-Based Therapeutics and Vaccines Products Introduction
5.7 miRagen Therapeutics
5.7.1 miRagen Therapeutics Company Profile
5.7.2 miRagen Therapeutics Business Overview
5.7.3 miRagen Therapeutics RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 miRagen Therapeutics RNA-Based Therapeutics and Vaccines Products Introduction
5.8 Dicerna Pharmaceuticals, Inc.
5.8.1 Dicerna Pharmaceuticals, Inc. Company Profile
5.8.2 Dicerna Pharmaceuticals, Inc. Business Overview
5.8.3 Dicerna Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Dicerna Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Products Introduction
5.9 Arrowhead Pharmaceuticals, Inc.
5.9.1 Arrowhead Pharmaceuticals, Inc. Company Profile
5.9.2 Arrowhead Pharmaceuticals, Inc. Business Overview
5.9.3 Arrowhead Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Arrowhead Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Products Introduction
5.10 CureVac AG
5.10.1 CureVac AG Company Profile
5.10.2 CureVac AG Business Overview
5.10.3 CureVac AG RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 CureVac AG RNA-Based Therapeutics and Vaccines Products Introduction
5.11 Marina Biotech, Inc.
5.11.1 Marina Biotech, Inc. Company Profile
5.11.2 Marina Biotech, Inc. Business Overview
5.11.3 Marina Biotech, Inc. RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Marina Biotech, Inc. RNA-Based Therapeutics and Vaccines Products Introduction
5.12 Moderna Therapeutics, Inc.
5.12.1 Moderna Therapeutics, Inc. Company Profile
5.12.2 Moderna Therapeutics, Inc. Business Overview
5.12.3 Moderna Therapeutics, Inc. RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Moderna Therapeutics, Inc. RNA-Based Therapeutics and Vaccines Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global RNA-Based Therapeutics and Vaccines Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global RNA-Based Therapeutics and Vaccines Sales and Market Share by Types (2015-2020)
6.1.2 Global RNA-Based Therapeutics and Vaccines Revenue and Market Share by Types (2015-2020)
6.1.3 Global RNA-Based Therapeutics and Vaccines Price by Types (2015-2020)
6.2 Global RNA-Based Therapeutics and Vaccines Market Forecast by Types (2020-2025)
6.2.1 Global RNA-Based Therapeutics and Vaccines Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global RNA-Based Therapeutics and Vaccines Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global RNA-Based Therapeutics and Vaccines Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global RNA-Based Therapeutics and Vaccines Sales, Price and Growth Rate of RNA-based Therapeutics
6.3.2 Global RNA-Based Therapeutics and Vaccines Sales, Price and Growth Rate of RNA-Based Vaccines
6.4 Global RNA-Based Therapeutics and Vaccines Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 RNA-based Therapeutics Market Revenue and Sales Forecast (2020-2025)
6.4.2 RNA-Based Vaccines Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global RNA-Based Therapeutics and Vaccines Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global RNA-Based Therapeutics and Vaccines Sales and Market Share by Applications (2015-2020)
7.1.2 Global RNA-Based Therapeutics and Vaccines Revenue and Market Share by Applications (2015-2020)
7.2 Global RNA-Based Therapeutics and Vaccines Market Forecast by Applications (2020-2025)
7.2.1 Global RNA-Based Therapeutics and Vaccines Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global RNA-Based Therapeutics and Vaccines Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global RNA-Based Therapeutics and Vaccines Revenue, Sales and Growth Rate of Oncology (2015-2020)
7.3.2 Global RNA-Based Therapeutics and Vaccines Revenue, Sales and Growth Rate of Immunology (2015-2020)
7.3.3 Global RNA-Based Therapeutics and Vaccines Revenue, Sales and Growth Rate of Ophthalmology (2015-2020)
7.3.4 Global RNA-Based Therapeutics and Vaccines Revenue, Sales and Growth Rate of Cardiovascular Diseases (2015-2020)
7.3.5 Global RNA-Based Therapeutics and Vaccines Revenue, Sales and Growth Rate of Infectious Diseases (2015-2020)
7.3.6 Global RNA-Based Therapeutics and Vaccines Revenue, Sales and Growth Rate of Genetic Diseases (2015-2020)
7.3.7 Global RNA-Based Therapeutics and Vaccines Revenue, Sales and Growth Rate of Others (2015-2020)
7.4 Global RNA-Based Therapeutics and Vaccines Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Oncology Market Revenue and Sales Forecast (2020-2025)
7.4.2 Immunology Market Revenue and Sales Forecast (2020-2025)
7.4.3 Ophthalmology Market Revenue and Sales Forecast (2020-2025)
7.4.4 Cardiovascular Diseases Market Revenue and Sales Forecast (2020-2025)
7.4.5 Infectious Diseases Market Revenue and Sales Forecast (2020-2025)
7.4.6 Genetic Diseases Market Revenue and Sales Forecast (2020-2025)
7.4.7 Others Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global RNA-Based Therapeutics and Vaccines Sales by Regions (2015-2020)
8.2 Global RNA-Based Therapeutics and Vaccines Market Revenue by Regions (2015-2020)
8.3 Global RNA-Based Therapeutics and Vaccines Market Forecast by Regions (2020-2025)
9 NORTH AMERICA RNA-BASED THERAPEUTICS AND VACCINES MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
9.3 North America RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
9.4 North America RNA-Based Therapeutics and Vaccines Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America RNA-Based Therapeutics and Vaccines Market Analysis by Country
9.6.1 U.S. RNA-Based Therapeutics and Vaccines Sales and Growth Rate
9.6.2 Canada RNA-Based Therapeutics and Vaccines Sales and Growth Rate
9.6.3 Mexico RNA-Based Therapeutics and Vaccines Sales and Growth Rate
10 EUROPE RNA-BASED THERAPEUTICS AND VACCINES MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
10.3 Europe RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
10.4 Europe RNA-Based Therapeutics and Vaccines Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe RNA-Based Therapeutics and Vaccines Market Analysis by Country
10.6.1 Germany RNA-Based Therapeutics and Vaccines Sales and Growth Rate
10.6.2 United Kingdom RNA-Based Therapeutics and Vaccines Sales and Growth Rate
10.6.3 France RNA-Based Therapeutics and Vaccines Sales and Growth Rate
10.6.4 Italy RNA-Based Therapeutics and Vaccines Sales and Growth Rate
10.6.5 Spain RNA-Based Therapeutics and Vaccines Sales and Growth Rate
10.6.6 Russia RNA-Based Therapeutics and Vaccines Sales and Growth Rate
11 ASIA-PACIFIC RNA-BASED THERAPEUTICS AND VACCINES MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Analysis by Country
11.6.1 China RNA-Based Therapeutics and Vaccines Sales and Growth Rate
11.6.2 Japan RNA-Based Therapeutics and Vaccines Sales and Growth Rate
11.6.3 South Korea RNA-Based Therapeutics and Vaccines Sales and Growth Rate
11.6.4 Australia RNA-Based Therapeutics and Vaccines Sales and Growth Rate
11.6.5 India RNA-Based Therapeutics and Vaccines Sales and Growth Rate
12 SOUTH AMERICA RNA-BASED THERAPEUTICS AND VACCINES MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
12.3 South America RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
12.4 South America RNA-Based Therapeutics and Vaccines Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America RNA-Based Therapeutics and Vaccines Market Analysis by Country
12.6.1 Brazil RNA-Based Therapeutics and Vaccines Sales and Growth Rate
12.6.2 Argentina RNA-Based Therapeutics and Vaccines Sales and Growth Rate
12.6.3 Columbia RNA-Based Therapeutics and Vaccines Sales and Growth Rate
13 MIDDLE EAST AND AFRICA RNA-BASED THERAPEUTICS AND VACCINES MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa RNA-Based Therapeutics and Vaccines Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa RNA-Based Therapeutics and Vaccines Market Analysis by Country
13.6.1 UAE RNA-Based Therapeutics and Vaccines Sales and Growth Rate
13.6.2 Egypt RNA-Based Therapeutics and Vaccines Sales and Growth Rate
13.6.3 South Africa RNA-Based Therapeutics and Vaccines Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
1.1 Product Definition and Market Characteristics
1.2 Global RNA-Based Therapeutics and Vaccines Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 Regulus Therapeutics, Inc.
5.1.1 Regulus Therapeutics, Inc. Company Profile
5.1.2 Regulus Therapeutics, Inc. Business Overview
5.1.3 Regulus Therapeutics, Inc. RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Regulus Therapeutics, Inc. RNA-Based Therapeutics and Vaccines Products Introduction
5.2 Arbutus Biopharma Corp.
5.2.1 Arbutus Biopharma Corp. Company Profile
5.2.2 Arbutus Biopharma Corp. Business Overview
5.2.3 Arbutus Biopharma Corp. RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Arbutus Biopharma Corp. RNA-Based Therapeutics and Vaccines Products Introduction
5.3 BioNTech AG
5.3.1 BioNTech AG Company Profile
5.3.2 BioNTech AG Business Overview
5.3.3 BioNTech AG RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 BioNTech AG RNA-Based Therapeutics and Vaccines Products Introduction
5.4 Alnylam Pharmaceuticals, Inc.
5.4.1 Alnylam Pharmaceuticals, Inc. Company Profile
5.4.2 Alnylam Pharmaceuticals, Inc. Business Overview
5.4.3 Alnylam Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Alnylam Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Products Introduction
5.5 Quark Pharmaceuticals, Inc.
5.5.1 Quark Pharmaceuticals, Inc. Company Profile
5.5.2 Quark Pharmaceuticals, Inc. Business Overview
5.5.3 Quark Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Quark Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Products Introduction
5.6 Santaris Pharma A/S (A Roche Company)
5.6.1 Santaris Pharma A/S (A Roche Company) Company Profile
5.6.2 Santaris Pharma A/S (A Roche Company) Business Overview
5.6.3 Santaris Pharma A/S (A Roche Company) RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Santaris Pharma A/S (A Roche Company) RNA-Based Therapeutics and Vaccines Products Introduction
5.7 miRagen Therapeutics
5.7.1 miRagen Therapeutics Company Profile
5.7.2 miRagen Therapeutics Business Overview
5.7.3 miRagen Therapeutics RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 miRagen Therapeutics RNA-Based Therapeutics and Vaccines Products Introduction
5.8 Dicerna Pharmaceuticals, Inc.
5.8.1 Dicerna Pharmaceuticals, Inc. Company Profile
5.8.2 Dicerna Pharmaceuticals, Inc. Business Overview
5.8.3 Dicerna Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Dicerna Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Products Introduction
5.9 Arrowhead Pharmaceuticals, Inc.
5.9.1 Arrowhead Pharmaceuticals, Inc. Company Profile
5.9.2 Arrowhead Pharmaceuticals, Inc. Business Overview
5.9.3 Arrowhead Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Arrowhead Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Products Introduction
5.10 CureVac AG
5.10.1 CureVac AG Company Profile
5.10.2 CureVac AG Business Overview
5.10.3 CureVac AG RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 CureVac AG RNA-Based Therapeutics and Vaccines Products Introduction
5.11 Marina Biotech, Inc.
5.11.1 Marina Biotech, Inc. Company Profile
5.11.2 Marina Biotech, Inc. Business Overview
5.11.3 Marina Biotech, Inc. RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Marina Biotech, Inc. RNA-Based Therapeutics and Vaccines Products Introduction
5.12 Moderna Therapeutics, Inc.
5.12.1 Moderna Therapeutics, Inc. Company Profile
5.12.2 Moderna Therapeutics, Inc. Business Overview
5.12.3 Moderna Therapeutics, Inc. RNA-Based Therapeutics and Vaccines Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Moderna Therapeutics, Inc. RNA-Based Therapeutics and Vaccines Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global RNA-Based Therapeutics and Vaccines Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global RNA-Based Therapeutics and Vaccines Sales and Market Share by Types (2015-2020)
6.1.2 Global RNA-Based Therapeutics and Vaccines Revenue and Market Share by Types (2015-2020)
6.1.3 Global RNA-Based Therapeutics and Vaccines Price by Types (2015-2020)
6.2 Global RNA-Based Therapeutics and Vaccines Market Forecast by Types (2020-2025)
6.2.1 Global RNA-Based Therapeutics and Vaccines Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global RNA-Based Therapeutics and Vaccines Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global RNA-Based Therapeutics and Vaccines Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global RNA-Based Therapeutics and Vaccines Sales, Price and Growth Rate of RNA-based Therapeutics
6.3.2 Global RNA-Based Therapeutics and Vaccines Sales, Price and Growth Rate of RNA-Based Vaccines
6.4 Global RNA-Based Therapeutics and Vaccines Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 RNA-based Therapeutics Market Revenue and Sales Forecast (2020-2025)
6.4.2 RNA-Based Vaccines Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global RNA-Based Therapeutics and Vaccines Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global RNA-Based Therapeutics and Vaccines Sales and Market Share by Applications (2015-2020)
7.1.2 Global RNA-Based Therapeutics and Vaccines Revenue and Market Share by Applications (2015-2020)
7.2 Global RNA-Based Therapeutics and Vaccines Market Forecast by Applications (2020-2025)
7.2.1 Global RNA-Based Therapeutics and Vaccines Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global RNA-Based Therapeutics and Vaccines Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global RNA-Based Therapeutics and Vaccines Revenue, Sales and Growth Rate of Oncology (2015-2020)
7.3.2 Global RNA-Based Therapeutics and Vaccines Revenue, Sales and Growth Rate of Immunology (2015-2020)
7.3.3 Global RNA-Based Therapeutics and Vaccines Revenue, Sales and Growth Rate of Ophthalmology (2015-2020)
7.3.4 Global RNA-Based Therapeutics and Vaccines Revenue, Sales and Growth Rate of Cardiovascular Diseases (2015-2020)
7.3.5 Global RNA-Based Therapeutics and Vaccines Revenue, Sales and Growth Rate of Infectious Diseases (2015-2020)
7.3.6 Global RNA-Based Therapeutics and Vaccines Revenue, Sales and Growth Rate of Genetic Diseases (2015-2020)
7.3.7 Global RNA-Based Therapeutics and Vaccines Revenue, Sales and Growth Rate of Others (2015-2020)
7.4 Global RNA-Based Therapeutics and Vaccines Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Oncology Market Revenue and Sales Forecast (2020-2025)
7.4.2 Immunology Market Revenue and Sales Forecast (2020-2025)
7.4.3 Ophthalmology Market Revenue and Sales Forecast (2020-2025)
7.4.4 Cardiovascular Diseases Market Revenue and Sales Forecast (2020-2025)
7.4.5 Infectious Diseases Market Revenue and Sales Forecast (2020-2025)
7.4.6 Genetic Diseases Market Revenue and Sales Forecast (2020-2025)
7.4.7 Others Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global RNA-Based Therapeutics and Vaccines Sales by Regions (2015-2020)
8.2 Global RNA-Based Therapeutics and Vaccines Market Revenue by Regions (2015-2020)
8.3 Global RNA-Based Therapeutics and Vaccines Market Forecast by Regions (2020-2025)
9 NORTH AMERICA RNA-BASED THERAPEUTICS AND VACCINES MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
9.3 North America RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
9.4 North America RNA-Based Therapeutics and Vaccines Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America RNA-Based Therapeutics and Vaccines Market Analysis by Country
9.6.1 U.S. RNA-Based Therapeutics and Vaccines Sales and Growth Rate
9.6.2 Canada RNA-Based Therapeutics and Vaccines Sales and Growth Rate
9.6.3 Mexico RNA-Based Therapeutics and Vaccines Sales and Growth Rate
10 EUROPE RNA-BASED THERAPEUTICS AND VACCINES MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
10.3 Europe RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
10.4 Europe RNA-Based Therapeutics and Vaccines Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe RNA-Based Therapeutics and Vaccines Market Analysis by Country
10.6.1 Germany RNA-Based Therapeutics and Vaccines Sales and Growth Rate
10.6.2 United Kingdom RNA-Based Therapeutics and Vaccines Sales and Growth Rate
10.6.3 France RNA-Based Therapeutics and Vaccines Sales and Growth Rate
10.6.4 Italy RNA-Based Therapeutics and Vaccines Sales and Growth Rate
10.6.5 Spain RNA-Based Therapeutics and Vaccines Sales and Growth Rate
10.6.6 Russia RNA-Based Therapeutics and Vaccines Sales and Growth Rate
11 ASIA-PACIFIC RNA-BASED THERAPEUTICS AND VACCINES MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Analysis by Country
11.6.1 China RNA-Based Therapeutics and Vaccines Sales and Growth Rate
11.6.2 Japan RNA-Based Therapeutics and Vaccines Sales and Growth Rate
11.6.3 South Korea RNA-Based Therapeutics and Vaccines Sales and Growth Rate
11.6.4 Australia RNA-Based Therapeutics and Vaccines Sales and Growth Rate
11.6.5 India RNA-Based Therapeutics and Vaccines Sales and Growth Rate
12 SOUTH AMERICA RNA-BASED THERAPEUTICS AND VACCINES MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
12.3 South America RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
12.4 South America RNA-Based Therapeutics and Vaccines Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America RNA-Based Therapeutics and Vaccines Market Analysis by Country
12.6.1 Brazil RNA-Based Therapeutics and Vaccines Sales and Growth Rate
12.6.2 Argentina RNA-Based Therapeutics and Vaccines Sales and Growth Rate
12.6.3 Columbia RNA-Based Therapeutics and Vaccines Sales and Growth Rate
13 MIDDLE EAST AND AFRICA RNA-BASED THERAPEUTICS AND VACCINES MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa RNA-Based Therapeutics and Vaccines Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa RNA-Based Therapeutics and Vaccines Market Analysis by Country
13.6.1 UAE RNA-Based Therapeutics and Vaccines Sales and Growth Rate
13.6.2 Egypt RNA-Based Therapeutics and Vaccines Sales and Growth Rate
13.6.3 South Africa RNA-Based Therapeutics and Vaccines Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Product Picture
Figure Global RNA-Based Therapeutics and Vaccines Market Size and Growth Rate 2015-2025
Table RNA-Based Therapeutics and Vaccines Key Market Segments
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) Segment by Type from 2015-2020
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of RNA-Based Therapeutics and Vaccines
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Regulus Therapeutics, Inc. Company Profile
Table Regulus Therapeutics, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Regulus Therapeutics, Inc. Production and Growth Rate
Figure Regulus Therapeutics, Inc. Market Revenue ($) Market Share 2015-2020
Table Arbutus Biopharma Corp. Company Profile
Table Arbutus Biopharma Corp. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Arbutus Biopharma Corp. Production and Growth Rate
Figure Arbutus Biopharma Corp. Market Revenue ($) Market Share 2015-2020
Table BioNTech AG Company Profile
Table BioNTech AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure BioNTech AG Production and Growth Rate
Figure BioNTech AG Market Revenue ($) Market Share 2015-2020
Table Alnylam Pharmaceuticals, Inc. Company Profile
Table Alnylam Pharmaceuticals, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Alnylam Pharmaceuticals, Inc. Production and Growth Rate
Figure Alnylam Pharmaceuticals, Inc. Market Revenue ($) Market Share 2015-2020
Table Quark Pharmaceuticals, Inc. Company Profile
Table Quark Pharmaceuticals, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Quark Pharmaceuticals, Inc. Production and Growth Rate
Figure Quark Pharmaceuticals, Inc. Market Revenue ($) Market Share 2015-2020
Table Santaris Pharma A/S (A Roche Company) Company Profile
Table Santaris Pharma A/S (A Roche Company) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Santaris Pharma A/S (A Roche Company) Production and Growth Rate
Figure Santaris Pharma A/S (A Roche Company) Market Revenue ($) Market Share 2015-2020
Table miRagen Therapeutics Company Profile
Table miRagen Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure miRagen Therapeutics Production and Growth Rate
Figure miRagen Therapeutics Market Revenue ($) Market Share 2015-2020
Table Dicerna Pharmaceuticals, Inc. Company Profile
Table Dicerna Pharmaceuticals, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Dicerna Pharmaceuticals, Inc. Production and Growth Rate
Figure Dicerna Pharmaceuticals, Inc. Market Revenue ($) Market Share 2015-2020
Table Arrowhead Pharmaceuticals, Inc. Company Profile
Table Arrowhead Pharmaceuticals, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Arrowhead Pharmaceuticals, Inc. Production and Growth Rate
Figure Arrowhead Pharmaceuticals, Inc. Market Revenue ($) Market Share 2015-2020
Table CureVac AG Company Profile
Table CureVac AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure CureVac AG Production and Growth Rate
Figure CureVac AG Market Revenue ($) Market Share 2015-2020
Table Marina Biotech, Inc. Company Profile
Table Marina Biotech, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Marina Biotech, Inc. Production and Growth Rate
Figure Marina Biotech, Inc. Market Revenue ($) Market Share 2015-2020
Table Moderna Therapeutics, Inc. Company Profile
Table Moderna Therapeutics, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Moderna Therapeutics, Inc. Production and Growth Rate
Figure Moderna Therapeutics, Inc. Market Revenue ($) Market Share 2015-2020
Table Global RNA-Based Therapeutics and Vaccines Sales by Types (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Sales Share by Types (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Revenue ($) by Types (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Revenue Share by Types (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Price ($) by Types (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Sales by Types (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Sales Share by Types (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Revenue ($) by Types (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Revenue Share by Types (2020-2025)
Figure Global RNA-based Therapeutics Sales and Growth Rate (2015-2020)
Figure Global RNA-based Therapeutics Price (2015-2020)
Figure Global RNA-Based Vaccines Sales and Growth Rate (2015-2020)
Figure Global RNA-Based Vaccines Price (2015-2020)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of RNA-based Therapeutics (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of RNA-based Therapeutics (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of RNA-Based Vaccines (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of RNA-Based Vaccines (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Sales by Applications (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Sales Share by Applications (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Revenue ($) by Applications (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Revenue Share by Applications (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Sales by Applications (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Sales Share by Applications (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Revenue ($) by Applications (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Oncology Sales and Growth Rate (2015-2020)
Figure Global Oncology Price (2015-2020)
Figure Global Immunology Sales and Growth Rate (2015-2020)
Figure Global Immunology Price (2015-2020)
Figure Global Ophthalmology Sales and Growth Rate (2015-2020)
Figure Global Ophthalmology Price (2015-2020)
Figure Global Cardiovascular Diseases Sales and Growth Rate (2015-2020)
Figure Global Cardiovascular Diseases Price (2015-2020)
Figure Global Infectious Diseases Sales and Growth Rate (2015-2020)
Figure Global Infectious Diseases Price (2015-2020)
Figure Global Genetic Diseases Sales and Growth Rate (2015-2020)
Figure Global Genetic Diseases Price (2015-2020)
Figure Global Others Sales and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of Oncology (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of Oncology (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of Immunology (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of Immunology (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of Ophthalmology (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of Ophthalmology (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of Cardiovascular Diseases (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of Cardiovascular Diseases (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of Infectious Diseases (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of Infectious Diseases (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of Genetic Diseases (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of Genetic Diseases (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of Others (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Sales by Regions (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Sales Market Share by Regions (2015-2020)
Figure Global RNA-Based Therapeutics and Vaccines Sales Market Share by Regions in 2019
Figure Global RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Revenue by Regions (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Regions (2015-2020)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Regions in 2019
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Sales by Regions (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Sales Share by Regions (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Revenue ($) by Regions (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Revenue Share by Regions (2020-2025)
Figure North America RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure North America RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
Figure North America RNA-Based Therapeutics and Vaccines Market Forecast Sales (2020-2025)
Figure North America RNA-Based Therapeutics and Vaccines Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Canada RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Mexico RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Europe RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Europe RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
Figure Europe RNA-Based Therapeutics and Vaccines Market Forecast Sales (2020-2025)
Figure Europe RNA-Based Therapeutics and Vaccines Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure United Kingdom RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure France RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Italy RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Spain RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Russia RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific RNA-Based Therapeutics and Vaccines Market Forecast Sales (2020-2025)
Figure Asia-Pacific RNA-Based Therapeutics and Vaccines Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Japan RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure South Korea RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Australia RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure India RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure South America RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure South America RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
Figure South America RNA-Based Therapeutics and Vaccines Market Forecast Sales (2020-2025)
Figure South America RNA-Based Therapeutics and Vaccines Market Forecast Revenue ($) (2020-2025)
Figure Brazil RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Argentina RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Columbia RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Market Forecast Sales (2020-2025)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Market Forecast Revenue ($) (2020-2025)
Figure UAE RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Egypt RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure South Africa RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Product Picture
Figure Global RNA-Based Therapeutics and Vaccines Market Size and Growth Rate 2015-2025
Table RNA-Based Therapeutics and Vaccines Key Market Segments
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) Segment by Type from 2015-2020
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of RNA-Based Therapeutics and Vaccines
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Regulus Therapeutics, Inc. Company Profile
Table Regulus Therapeutics, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Regulus Therapeutics, Inc. Production and Growth Rate
Figure Regulus Therapeutics, Inc. Market Revenue ($) Market Share 2015-2020
Table Arbutus Biopharma Corp. Company Profile
Table Arbutus Biopharma Corp. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Arbutus Biopharma Corp. Production and Growth Rate
Figure Arbutus Biopharma Corp. Market Revenue ($) Market Share 2015-2020
Table BioNTech AG Company Profile
Table BioNTech AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure BioNTech AG Production and Growth Rate
Figure BioNTech AG Market Revenue ($) Market Share 2015-2020
Table Alnylam Pharmaceuticals, Inc. Company Profile
Table Alnylam Pharmaceuticals, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Alnylam Pharmaceuticals, Inc. Production and Growth Rate
Figure Alnylam Pharmaceuticals, Inc. Market Revenue ($) Market Share 2015-2020
Table Quark Pharmaceuticals, Inc. Company Profile
Table Quark Pharmaceuticals, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Quark Pharmaceuticals, Inc. Production and Growth Rate
Figure Quark Pharmaceuticals, Inc. Market Revenue ($) Market Share 2015-2020
Table Santaris Pharma A/S (A Roche Company) Company Profile
Table Santaris Pharma A/S (A Roche Company) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Santaris Pharma A/S (A Roche Company) Production and Growth Rate
Figure Santaris Pharma A/S (A Roche Company) Market Revenue ($) Market Share 2015-2020
Table miRagen Therapeutics Company Profile
Table miRagen Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure miRagen Therapeutics Production and Growth Rate
Figure miRagen Therapeutics Market Revenue ($) Market Share 2015-2020
Table Dicerna Pharmaceuticals, Inc. Company Profile
Table Dicerna Pharmaceuticals, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Dicerna Pharmaceuticals, Inc. Production and Growth Rate
Figure Dicerna Pharmaceuticals, Inc. Market Revenue ($) Market Share 2015-2020
Table Arrowhead Pharmaceuticals, Inc. Company Profile
Table Arrowhead Pharmaceuticals, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Arrowhead Pharmaceuticals, Inc. Production and Growth Rate
Figure Arrowhead Pharmaceuticals, Inc. Market Revenue ($) Market Share 2015-2020
Table CureVac AG Company Profile
Table CureVac AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure CureVac AG Production and Growth Rate
Figure CureVac AG Market Revenue ($) Market Share 2015-2020
Table Marina Biotech, Inc. Company Profile
Table Marina Biotech, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Marina Biotech, Inc. Production and Growth Rate
Figure Marina Biotech, Inc. Market Revenue ($) Market Share 2015-2020
Table Moderna Therapeutics, Inc. Company Profile
Table Moderna Therapeutics, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Moderna Therapeutics, Inc. Production and Growth Rate
Figure Moderna Therapeutics, Inc. Market Revenue ($) Market Share 2015-2020
Table Global RNA-Based Therapeutics and Vaccines Sales by Types (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Sales Share by Types (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Revenue ($) by Types (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Revenue Share by Types (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Price ($) by Types (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Sales by Types (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Sales Share by Types (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Revenue ($) by Types (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Revenue Share by Types (2020-2025)
Figure Global RNA-based Therapeutics Sales and Growth Rate (2015-2020)
Figure Global RNA-based Therapeutics Price (2015-2020)
Figure Global RNA-Based Vaccines Sales and Growth Rate (2015-2020)
Figure Global RNA-Based Vaccines Price (2015-2020)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of RNA-based Therapeutics (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of RNA-based Therapeutics (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of RNA-Based Vaccines (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of RNA-Based Vaccines (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Sales by Applications (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Sales Share by Applications (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Revenue ($) by Applications (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Revenue Share by Applications (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Sales by Applications (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Sales Share by Applications (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Revenue ($) by Applications (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Oncology Sales and Growth Rate (2015-2020)
Figure Global Oncology Price (2015-2020)
Figure Global Immunology Sales and Growth Rate (2015-2020)
Figure Global Immunology Price (2015-2020)
Figure Global Ophthalmology Sales and Growth Rate (2015-2020)
Figure Global Ophthalmology Price (2015-2020)
Figure Global Cardiovascular Diseases Sales and Growth Rate (2015-2020)
Figure Global Cardiovascular Diseases Price (2015-2020)
Figure Global Infectious Diseases Sales and Growth Rate (2015-2020)
Figure Global Infectious Diseases Price (2015-2020)
Figure Global Genetic Diseases Sales and Growth Rate (2015-2020)
Figure Global Genetic Diseases Price (2015-2020)
Figure Global Others Sales and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of Oncology (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of Oncology (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of Immunology (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of Immunology (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of Ophthalmology (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of Ophthalmology (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of Cardiovascular Diseases (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of Cardiovascular Diseases (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of Infectious Diseases (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of Infectious Diseases (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of Genetic Diseases (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of Genetic Diseases (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate Forecast of Others (2020-2025)
Figure Global RNA-Based Therapeutics and Vaccines Sales and Growth Rate (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Sales by Regions (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Sales Market Share by Regions (2015-2020)
Figure Global RNA-Based Therapeutics and Vaccines Sales Market Share by Regions in 2019
Figure Global RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Revenue by Regions (2015-2020)
Table Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Regions (2015-2020)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Regions in 2019
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Sales by Regions (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Sales Share by Regions (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Revenue ($) by Regions (2020-2025)
Table Global RNA-Based Therapeutics and Vaccines Market Forecast Revenue Share by Regions (2020-2025)
Figure North America RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure North America RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
Figure North America RNA-Based Therapeutics and Vaccines Market Forecast Sales (2020-2025)
Figure North America RNA-Based Therapeutics and Vaccines Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Canada RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Mexico RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Europe RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Europe RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
Figure Europe RNA-Based Therapeutics and Vaccines Market Forecast Sales (2020-2025)
Figure Europe RNA-Based Therapeutics and Vaccines Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure United Kingdom RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure France RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Italy RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Spain RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Russia RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific RNA-Based Therapeutics and Vaccines Market Forecast Sales (2020-2025)
Figure Asia-Pacific RNA-Based Therapeutics and Vaccines Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Japan RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure South Korea RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Australia RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure India RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure South America RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure South America RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
Figure South America RNA-Based Therapeutics and Vaccines Market Forecast Sales (2020-2025)
Figure South America RNA-Based Therapeutics and Vaccines Market Forecast Revenue ($) (2020-2025)
Figure Brazil RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Argentina RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Columbia RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Market Forecast Sales (2020-2025)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Market Forecast Revenue ($) (2020-2025)
Figure UAE RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure Egypt RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
Figure South Africa RNA-Based Therapeutics and Vaccines Market Sales and Growth Rate (2015-2020)
